Oncosil Medical Limited

Appendix 2A (Application for Quotation of Securities)

Corporate Governance, Appendix 4G

Annual Report, Preliminary Final Report, Periodic Reports - Other

Annual Report, Top 20 shareholders, Full Year Accounts, Full Year Audit Review, Full Year Directors' Statement, Full Year Directors' Report

Company Administration - Other

January 2016

Conditions may be bad but in 1997 they were also bad and 1998 was expected to be far worse, but then the sharemarket boomed.

Listed biotech OncoSil Medical is seeking to raise $10.3 million to fund a pancreatic cancer study.